Q: What is diabetic retinopathy? A: Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. Diabetic retinopathy is a progressive disease that destroys small blood vessels in the retina, eventually causing vision problems. In its most advanced form–proliferative retinopathy–it can cause blindness. According to the National […]
Congress passed the Special Diabetes Program (SDP) in December 2010, committing $150 million per year to extend the program for an additional two years. The legislation marks the fifth time since 1997 that Congress has supported SDP, underscoring the government’s commitment to accelerating the search for a cure and the development of new treatments for […]
By Kathryn Larson I still wonder, “What was I thinking?” I had spent my entire life in a secure community near Denver, yet when I was presented with the opportunity to take a two-week tour of Vietnam, I jumped at it – in spite of the fact that not only was I new to travel, […]
JDRF and Amylin are enthusiastic about the potential of metreleptin to help improve blood glucose control in people with type 1 diabetes. A successful outcome in the metreleptin study would likely lead to studies with larger numbers of people and the development of alternative treatments to using medical insulin alone.
A simple insulin-infusion warming device, called the InsuPatch, accelerates insulin delivery into the bloodstream by as much as 35 minutes. Speeding up the delivery and action of insulin and reducing the amount of time patients spend in a hyperglycemic state potentially reduces the risk of complications that result from the disease.
Adding metreleptin to insulin therapy improves blood glucose control and helps regulate blood lipid (including cholesterol) levels, according to a new study conducted on rodents. Metreleptin is closely related to the human hormone leptin, which plays a fundamental role in the regulation of fat and glucose metabolism in the body. A new clinical trial, funded […]
The closed-loop artificial pancreas, which combines an insulin pump with a glucose monitor, has been successfully tested on people in controlled hospital settings. Now, researchers believe that it is time to try this innovation in real-life environments. Last summer, JDRF formed a panel of experts to provide advice about how to bring this technology out […]
JDRF and its JDRF Israel affiliate have established a research partnership with the Israel Science Foundation (ISF), a prominent research organization in Israel, to encourage innovative research focused on accelerating progress toward a cure for type 1 diabetes. JDRF and ISF are committing up to $3 million each over a three-year period to support type […]
On August 3, JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust, announced the award of a $4.6 million grant to the laboratory of Camillo Ricordi, M.D., of the Diabetes Research Institute at the University of Miami. The three-year grant will fund research in the area of beta cell encapsulation, a […]